Composite bone substitute materials based on β-tricalcium phosphate and magnesium-containing sol–gel derived bioactive glass

  • Saeed Hesaraki
  • Mojgan Safari
  • Mohammad Ali Shokrgozar


In the present study, bioceramic composites with improved mechanical and biological properties were synthesized by sintering mixtures of β-tricalcium phosphate and SiO2–CaO–MgO–P2O5 sol–gel derived bioactive glass at 1000–1200°C. The physical, mechanical, structural and biological properties of the composites were evaluated by appropriate experiments such as microhardness, bending strength, XRD, SEM and MTT. The results showed that 1000 and 1100°C were not appropriate temperatures for sintering the composites and in contrast, the microhardness, bending strength and bulk density significantly increased by increasing in quantity of bioglass phase when the samples were sintered at 1200°C. No significant difference was found between the fracture toughness of the composites and pure β-tricalcium phosphate. β-tricalcium phosphate was structurally stable up to 1200°C and did not transform to its alpha form even in the presence of the bioglass phase but migration of magnesium cations from the glass composition into its lattice structure was found by right-shift in XRD patterns, especially when the composite contained higher amount of bioglass component. Calcium silicate was also crystallized in the composition of the composites, which was more detectable in higher sintering temperatures. The results of the MTT test showed that proliferation of human osteosarcoma cells on the composites was considerably better than that of pure β-TCP.


Fracture Toughness Bioactive Glass Bone Graft Substitute Magnesium Nitrate Bend Strength 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors gratefully acknowledge Mr. Nader Nezafati for his collaboration and help in this work.


  1. 1.
    Constantz BR, Ison IC, Fulmer MT, Poser RD, Smith ST, Van Wagoner M, et al. Skeletal repair by in situ formation of the mineral phase of bone. Science. 1995;267:1796–9. doi: 10.1126/science.7892603.PubMedCrossRefADSGoogle Scholar
  2. 2.
    Vallet-Regi M, Gonzalez-Calbet JM. Calcium phosphates as substitution of bone tissues. Prog Solid State Chem. 2004;32:1–31. doi: 10.1016/j.progsolidstchem.2004.07.001.CrossRefGoogle Scholar
  3. 3.
    Ransford AQ, Morley T, Edgar MA, Webb P, Passuti N, Chopin D, et al. Synthetic porous ceramic compared with autograft in scoliosis surgery: a prospective, randomised study of 341 patients. J Bone Joint Surg Br. 1998;80B:13. doi: 10.1302/0301-620X.80B1.7276.CrossRefGoogle Scholar
  4. 4.
    Bohner M. Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. Injury. 2000;31:37–47. doi: 10.1016/S0020-1383(00)80022-4.PubMedCrossRefGoogle Scholar
  5. 5.
    Dorozhkin SV. Calcium orthophosphates. J Mater Sci. 2007;42:1061–95. doi: 10.1007/s10853-006-1467-8.CrossRefADSGoogle Scholar
  6. 6.
    Knowles JC, Bonfield W. Development of a glass reinforced hydroxyapatite with enhanced mechanical properties. The effect of glass composition on mechanical properties and its relationship to phase changes. J Biomed Mater Res. 1993;27:1591–8. doi: 10.1002/jbm.820271217.PubMedCrossRefGoogle Scholar
  7. 7.
    Lopes MA, Monteiro FJ, Santos JD. Glass-reinforced hydroxyapatite composites: secondary phase proportions and densification effects on biaxial bending strength. J Biomed Mater Res. 1999;48:734–40. doi: 10.1002/(SICI)1097-4636(1999)48:5<734::AID-JBM20>3.0.CO;2-2.PubMedCrossRefGoogle Scholar
  8. 8.
    Georgiou G, Knowles JC. Glass reinforced hydroxyapatite for hard tissue surgery—Part 1: mechanical properties. Biomaterials. 2001;22:2811–5. doi: 10.1016/S0142-9612(01)00025-4.PubMedCrossRefGoogle Scholar
  9. 9.
    Park K, Vasilosa T. Microstructure and mechanical properties of silicon carbide whisker/calcium phosphate composites produced by hot pressing. Mater Lett. 1997;32:229–33. doi: 10.1016/S0167-577X(97)00041-4.CrossRefGoogle Scholar
  10. 10.
    Hench L. Engineered materials handbook, vol. 4, Ceramics and glasses. Metals Park, OH: ASM International; 1991. p. 1007.Google Scholar
  11. 11.
    Xin R, Leng Y, Chen J, Zhang Q. A comparative study of calcium phosphate formation on bioceramics in vitro and in vivo. Biomaterials. 2005;26:6477–86. doi: 10.1016/j.biomaterials.2005.04.028.PubMedCrossRefGoogle Scholar
  12. 12.
    Yu X,Cai S, Zhang Z, Guohua X. Bioactive pyrophosphate glass/beta-tricalcium phosphate composite with high mechanical properties. Mater Sci Eng C. 2008;28:1138–43.CrossRefGoogle Scholar
  13. 13.
    Saboori A, Sheikhi M, Moztarzadeh F, Rabiee M, Hesaraki S, Tahriri M, et al. Sol-gel preparation, characterisation and in vitro bioactivity of Mg containing bioactive glass. Adv Appl Ceram. 2009;108:155–61. doi: 10.1179/174367608X324054.CrossRefGoogle Scholar
  14. 14.
    Oki A, Parveen B, Hossain S, Adeniji S, Donahue H. Preparation and in vitro bioactivity of zinc containing sol-gel-derived bioglass materials. J Biomed Mater Res A. 2004;69:216–21. doi: 10.1002/jbm.a.20070.PubMedCrossRefGoogle Scholar
  15. 15.
    Hesaraki S, Zamanian A, Moztarzadeh F. The influence of the acidic component of the gas-foaming porogen used in preparing an injectable porous calcium phosphate cement on its properties: acetic acid versus citric acid. J Biomed Mater Res B. 2008;86:208–16. doi: 10.1002/jbm.b.31008.Google Scholar
  16. 16.
    Lawn BR, Fuller ER. Equilibrium penny-like cracks in indentation fracture. J Mater Sci. 1975;10:2016–24. doi: 10.1007/BF00557479.CrossRefADSGoogle Scholar
  17. 17.
    Balamurugan A, Balossier G, Michel J, Kannan S, Benhayoune H, Rebelo AH, et al. Sol gel derived SiO2-CaO-MgO-P2O5 bioglass system—preparation and in vitro characterization. J Biomed Mater Res B. 2007;83:546–53. doi: 10.1002/jbm.b.30827.Google Scholar
  18. 18.
    Wu C, Ramaswamy Y, Kwik D, Zreiqat H. The effect of strontium incorporation into CaSiO3 ceramics on their physical and biological properties. Biomaterials. 2007;28:3171–81. doi: 10.1016/j.biomaterials.2007.04.002.PubMedCrossRefGoogle Scholar
  19. 19.
    Kim SR, Lee JH, Riu DH, Jung SJ, Lee YJ, Chung SC, et al. Synthesis of Si, Mg substituted hydroxyapatites and their sintering behaviors. Biomaterials. 2003;24:1389–98. doi: 10.1016/S0142-9612(02)00523-9.PubMedCrossRefGoogle Scholar
  20. 20.
    Okazaki M. Crystallographic properties of heterogeneous Mg-containing fluoridated apatites synthesized with a two-step supply system. Biomaterials. 1995;16:703–7. doi: 10.1016/0142-9612(95)99698-L.PubMedCrossRefGoogle Scholar
  21. 21.
    Percival M. Bone health & osteoporosis. Appl Nutr Sci Rep. 1999;5:1–5.Google Scholar
  22. 22.
    Hing K, Revell P, Smith N, Buckland T. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials. 2006;27:5014–26. doi: 10.1016/j.biomaterials.2006.05.039.PubMedCrossRefGoogle Scholar
  23. 23.
    Reffitt D, Ogston N, Jugdaohsingh R, Cheung H, Evans B, Thompson R, et al. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003;32:127. doi: 10.1016/S8756-3282(02)00950-X.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Saeed Hesaraki
    • 1
  • Mojgan Safari
    • 1
  • Mohammad Ali Shokrgozar
    • 2
  1. 1.Ceramics DepartmentMaterials and Energy Research CenterTehranIran
  2. 2.National Cell Bank of IranPasteur Institute of IranTehranIran

Personalised recommendations